WebbStock code: 00656: Name of listed corporation: Fosun International Ltd. Name of director: Guo Guangchang: Date (dd/mm/yyyy): 06/04/2024 - 06/04/2024: Please click the links under the column "Date of relevant event" to view the details of the DI notices. Webb16 mars 2024 · Shanghai Henlius Biotech, Inc. entered into the Fosun Pharma Industrial Technical Services Agreement with Fosun Pharma Industrial, pursuant to which the Company agreed to provide CMC and preclinical toxicological research services to Fosun Pharma Industrial in relation to an antibody drug FS2101 being developed by Fosun …
Shanghai Henlius Biotech SEHK:2696 Stock Report - Simply Wall St
Webb15 okt. 2024 · Shanghai, China, October 15th, 2024- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company entered into a co-development and exclusive … Webb12 apr. 2024 · Shanghai Henlius Biotech Inc. is a China-based company principally involved in the research, development, production and sales of monoclonal antibody products. floor pillows for sleeping
Alligator Bioscience meddelar avslutad patientrekrytering i fas 2 ...
Webb11 apr. 2024 · hong kong stock exchange filing: fosun international's founder guo guangchang bought 53,800 h-shares of shanghai henlius biotech 2 2696 at avg price of hk$12.2 ($1.55) per share on april 6 - hkex filing. guo's long position in h-shares of shanghai henlius biotech rises to 21.03% from 20.99% - hkex filing WebbHengenix Biotech, Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of … WebbShanghai Henlius Biotech , Inc. 2012 年 8 月 - 2024 年 6 月 4 年 11 个月 Theraputic antibody early-stage discovery, include phage library, cDNA of viable region cloning, functional assay development (immunotherapyand tumor associated target … great place to work r institute